Halozyme Therapeutics
HALOHalozyme Therapeutics is a U.S. biotechnology company that develops novel oncology therapies designed to target the tumor microenvironment and licenses a novel drug delivery technology through corporate partnerships. The company was founded in 1998 and went public in 2004. Halozyme is headquartered …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2023-2025
All insider trades at Halozyme Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 12/1/2025 | Sell | Torley, Helen | PRESIDENT AND CEO | $70.0 | $1,141,925 |
| 12/1/2025 | Sell | Connaughton, Bernadette | Director | $71.6 | $59,356 |
| 11/12/2025 | Sell | Torley, Helen | PRESIDENT AND CEO | $71.0 | $1,410,991 |
| 11/11/2025 | Sell | Torley, Helen | PRESIDENT AND CEO | $68.8 | $1,382,600 |
| 11/10/2025 | Sell | Connaughton, Bernadette | Director | $68.5 | $136,960 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)